Evidence map›Paper›PMID 40745386›Full record

ArticleCommunications biology2025

Connecting chemical structure to single cell signaling profiles.

Hannah L Thirman, Madeline J Grider-Hayes, Laura C Geben, Rebecca A Ihrie, Lauren E Brown, John A Porco, Jonathan M Irish

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. A Dimeric Rocaglate Promotes Multivalent eIF4A-RNA Assembly.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hannah L ThirmanDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-3735-9995
Madeline J Grider-HayesDepartment of Pediatrics-Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID http://orcid.org/0000-0003-3684-9885
Laura C GebenDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-0604-4808
Rebecca A IhrieDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-0439-0141
Lauren E BrownDepartment of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9489-484X
John A PorcoDepartment of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2991-5680
Jonathan M IrishDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA. jonathan.irish@cuanschutz.edu.ORCID http://orcid.org/0000-0001-9428-8866

Funding

TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Chemical Synthesis of Complex Natural Products for Translational ScienceR35GM118173 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI JOHN A. PORCO · 2016 to 2026
$8.2M
Single Cell Methods for Bioeffector Discovery and AnalysisR01CA226833 · NCI · VANDERBILT UNIVERSITY · PI BRIAN O BACHMANN, Jonathan Michael Irish · 2019 to 2026
$6.1M
BU-CMD Chemical Library Consortium: Fostering Collaborations between Chemists and Biologists for Translational DiscoveryU01TR002625 · NCATS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI PORCO, JOHN A. · 2020 to 2023
$2.7M
Identifying mTOR Dependent Periods During Brain DevelopmentR01NS118580 · NINDS · VANDERBILT UNIVERSITY · PI ESS, KEVIN C, IHRIE, REBECCA A · 2020 to 2024
$2.1M
Vanderbilt Chemical Biology Interface Training ProgramT32GM149371 · NIGMS · VANDERBILT UNIVERSITY · PI Lars Plate · 2023 to 2026
$1.7M
Mapping the Time Course of mTORC1-Driven Tumorigenesis in the Developing BrainF31NS120608 · NINDS · VANDERBILT UNIVERSITY · PI GEBEN, LAURA CATHERINE · 2021 to 2022
$67k
NCATS NIH HHS U01 TR002625NCI NIH HHS R01 CA226833NIGMS NIH HHS R35 GM118173NIGMS NIH HHS T32 GM007628NIGMS NIH HHS T32 GM149371NINDS NIH HHS F31 NS120608NINDS NIH HHS R01 NS118580
6 · The paper itself

Abstract

A challenge in chemical biology is to study structure-activity relationships (SAR) in vivo in cells. Multiplexed activity profiling (MAP), developed for natural product discovery, is well-suited to address this challenge as it is high throughput, singlecell, and measures multiple hallmark cellular functions. Applying MAP while systematically varying molecular structure (SAR-MAP) could reveal previously unappreciated activity within chemical families and prioritize candidate molecules for further characterization. Here we use SAR-MAP to identify structural features responsible for specific bioactivities of the natural product family, rocaglates. MV411 leukemia cells and healthy human leukocytes are selected for proof-of-concept screening. Testing 600 representative molecules using MAP classifies roughly half of tested rocaglates (9 of 19) as bioactive. SAR-MAP elucidates a methoxy substituent on select rocaglate pyrimidinones as responsible for a desirable anti-leukemia activity. Thus, SAR-MAP can be immediately applied to identify structural variations driving natural product activity in cell lines and primary human cells.

Indexed as

BenzofuransBiological ProductsSignal TransductionSingle-Cell AnalysisCell Line, TumorHumansMolecular StructureStructure-Activity RelationshipBenzofuransBiological Products

Identifiers

PMID40745386
PMCPMC12313981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.